Current Affairs & MCQs
Latest Questions, Daily Updates & More

Science & Technology MCQs - 2026-04-04

21.
This initiative aligns with India's vision of developing:
A Rural infrastructure
B Smart Cities
C Space exploration programs
D Agricultural technology
22.
Which of the following is a potential environmental benefit of this AI-powered transit system?
A Increased air pollution
B Higher fuel consumption
C Reduced carbon emissions
D Increased traffic congestion
23.
How does the AI system benefit passengers?
A By increasing ticket prices
B By providing real-time bus location and arrival information
C By reducing the number of bus routes
D By eliminating the need for public transport
24.
What is a primary function of the AI system in Kochi's public transit?
A Manufacturing new buses
B Optimizing routes, schedules, and fleet management
C Training bus drivers
D Collecting fares manually
25.
Which Indian city has launched the country's first AI-powered public transit system?
A Bengaluru
B Mumbai
C Kochi
D Delhi
26.
What is a significant potential benefit of this CRISPR-based therapy?
A It requires lifelong blood transfusions.
B It offers a potential one-time curative treatment.
C It is primarily a palliative care measure.
D It has significant side effects similar to chemotherapy.
27.
What does 'ex vivo' editing mean in the context of this therapy?
A The gene editing is performed directly inside the patient's body.
B The gene editing is performed on cells outside the patient's body.
C The gene editing is performed on a laboratory animal.
D The gene editing is performed on a synthesized DNA strand.
28.
What is the role of fetal hemoglobin (HbF) in this therapy?
A It is the defective form of hemoglobin that needs to be corrected.
B It is a protein that helps in blood clotting.
C It can compensate for the defective adult hemoglobin in patients.
D It is a marker for diagnosing the genetic disorder.
29.
Which of the following are genetic blood disorders that this CRISPR-based therapy aims to treat?
A Leukemia and Lymphoma
B Sickle cell anemia and beta-thalassemia
C Hemophilia and Von Willebrand disease
D Anaplastic anemia and Myelodysplastic syndromes
30.
What is the primary technology used in the new therapy for genetic blood disorders?
A mRNA vaccine technology
B CRISPR-Cas9 gene editing
C Stem cell transplantation
D Gene therapy using viral vectors